The global Nanoparticles Market Growth Accelerated by Wide Range of Applications in Healthcare


 Nanoparticles play a key role in various healthcare and biomedical applications owing to their unique properties such as size, magnetic properties, optical properties, and ability to cross biological barriers. They find usage in drug and gene delivery, medical imaging, catalysis, bioseparation, biomedical devices, and more. This has significantly increased demand for nanoparticles over the past few years.

The global Nanoparticles Market is estimated to be valued at US$ 16700.18 Mn in 2024 and is expected to exhibit a CAGR of 5.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
Wide range of applications is one of the major trends driving the growth of the nanoparticles market. Nanoparticles find usage across various industries including healthcare, electronics, energy, and packaging among others. In healthcare sector alone, they are widely used for drug and gene delivery, medical imaging, tissue engineering, bioseparation, and many other biomedical applications. Nanoparticles based drug delivery system provide advantages like site specific drug targeting, controlled release of drugs, solubilization of insoluble drugs, and reduced toxicity. Growing demand from healthcare industry for development of advanced treatment options is a key factor propelling the demand for nanoparticles over the forecast period.

Segment Analysis

The global nanoparticles market is divided into various segments based on type and application. Based on type, the metal & metal oxide nanoparticles segment dominated the market in 2023. Metal & metal oxides like silver, iron, zinc, copper and titanium nanoparticles have widespread applications across industries like healthcare, electronics, and personal care & cosmetics. Their antibacterial and UV blocking properties have made them useful for products like wound dressings, sunscreens and clothing materials. This has resulted in the metal & metal oxide nanoparticles segment occupying over 30% share of the global nanoparticles market in 2023.

Key Takeaways

The global nanoparticles market is expected to witness high growth in the coming years. With their unique size-dependent properties, nanoparticles find applications across industries and in newer fields like drug delivery, tissue engineering and biomedical imaging. The rising investments in R&D of nanotechnology and growing demand from end-use industries will continue to drive innovations and new opportunities. The global Nanoparticles Market is estimated to be valued at US$ 16700.18 Mn in 2024 and is expected to exhibit a CAGR of 5.0% over the forecast period 2023 to 2030.

Regional analysis: The Asia Pacific region currently dominates the global nanoparticles market with over 35% share. This can be attributed to the large manufacturing base of electronics and healthcare products in countries like China, India, Japan and South Korea. Additionally, growing medical device industry in these countries is expected to boost the demand for metal and metal oxide nanoparticles used in tissue engineering and drug delivery applications. Europe and North America are other major markets, though their growth rate is projected to be lower than Asia Pacific in the forecast period.

Key players: Key players operating in the nanoparticles market are Malvern Panalytical, Novartis International AG, Abraxis Bioscience, Bio-Rad Laboratories, Merck, NanoPlatform, Gemphire Therapeutics, Briglin & Power Company and Anthropic. Malvern Panalytical offers particle characterization solutions like dynamic light scattering for nanoparticle size analysis. Novartis is a leading pharmaceutical company exploring applications of nanoparticles in drug delivery.

Comments

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure